1. Home
  2. CRGX vs IIM Comparison

CRGX vs IIM Comparison

Compare CRGX & IIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • IIM
  • Stock Information
  • Founded
  • CRGX 2021
  • IIM 1993
  • Country
  • CRGX United States
  • IIM United States
  • Employees
  • CRGX N/A
  • IIM N/A
  • Industry
  • CRGX
  • IIM Investment Managers
  • Sector
  • CRGX
  • IIM Finance
  • Exchange
  • CRGX Nasdaq
  • IIM Nasdaq
  • Market Cap
  • CRGX 628.6M
  • IIM 582.9M
  • IPO Year
  • CRGX 2023
  • IIM N/A
  • Fundamental
  • Price
  • CRGX $3.74
  • IIM $12.27
  • Analyst Decision
  • CRGX Hold
  • IIM
  • Analyst Count
  • CRGX 7
  • IIM 0
  • Target Price
  • CRGX $4.67
  • IIM N/A
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • IIM 122.2K
  • Earning Date
  • CRGX 03-20-2025
  • IIM 01-01-0001
  • Dividend Yield
  • CRGX N/A
  • IIM 4.63%
  • EPS Growth
  • CRGX N/A
  • IIM N/A
  • EPS
  • CRGX N/A
  • IIM 0.02
  • Revenue
  • CRGX N/A
  • IIM N/A
  • Revenue This Year
  • CRGX N/A
  • IIM N/A
  • Revenue Next Year
  • CRGX N/A
  • IIM N/A
  • P/E Ratio
  • CRGX N/A
  • IIM $591.50
  • Revenue Growth
  • CRGX N/A
  • IIM N/A
  • 52 Week Low
  • CRGX $3.00
  • IIM $9.94
  • 52 Week High
  • CRGX $33.92
  • IIM $12.32
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • IIM 63.42
  • Support Level
  • CRGX $3.00
  • IIM $11.91
  • Resistance Level
  • CRGX $3.88
  • IIM $12.02
  • Average True Range (ATR)
  • CRGX 0.92
  • IIM 0.08
  • MACD
  • CRGX -1.00
  • IIM 0.04
  • Stochastic Oscillator
  • CRGX 5.99
  • IIM 100.00

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About IIM Invesco Value Municipal Income Trust

Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income which is exempt from federal income tax.

Share on Social Networks: